4/A//SEC Filing
Cai Tao 4/A
Accession 0001144204-11-033196
CIK 0001271057other
Filed
May 30, 8:00 PM ET
Accepted
May 31, 3:43 PM ET
Size
6.0 KB
Accession
0001144204-11-033196
Insider Transaction Report
Form 4/AAmended
Cai Tao
Chief Financial Officer
Transactions
- Award
Options (right to buy)
2011-01-16+150,000→ 150,000 totalExercise: $15.38Exp: 2021-01-16→ Common Stock (150,000 underlying)
Footnotes (2)
- [F1]This Form 4 is being amended to correct the exercise price of the options reported in Table II, which, due to an error, was initially disclosed as $14.81.
- [F2]The options vest in a series of 48 monthly installments such that 20% of the options will have vested by the first anniversary of the grant date, 20% of the options will have vested by the second anniversary of the grant date, 30% of the options will have vested by the third anniversary of the grant date and 30% of the options will have vested by the fourth anniversary of the grant date. The options will become exercisable only upon approval of the 2010 Equity Incentive Plan by the Company's stockholders.
Documents
Issuer
CHINA-BIOTICS, INC
CIK 0001271057
Entity typeother
Related Parties
1- filerCIK 0001482869
Filing Metadata
- Form type
- 4/A
- Filed
- May 30, 8:00 PM ET
- Accepted
- May 31, 3:43 PM ET
- Size
- 6.0 KB